Avidity Biosciences shares are trading lower after the company proposed a $250 million public offering of common stock.
Portfolio Pulse from Benzinga Newsdesk
Avidity Biosciences shares are trading lower after the company proposed a $250 million public offering of common stock.
August 14, 2024 | 2:37 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Avidity Biosciences shares are trading lower after the company proposed a $250 million public offering of common stock.
The announcement of a public offering typically dilutes existing shares, leading to a decrease in share price. Investors may react negatively in the short term due to the potential dilution of their holdings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100